References

1.     Van Den Wyngaert T, Strobel K, Kampen WU, Kuwert T, Van Der Bruggen W, et al. The EANM practice guidelines for bone scintigraphy. Eur J Nucl Med Mol Imaging. 2016 Aug;43(9):1723–38.

2.     Mattsson S, Johansson L, Leide Svegborn S, Liniecki J, Noßke D, Riklund KÅ, et al. ICRP Publication 128: Radiation Dose to Patients from Radiopharmaceuticals: a Compendium of Current Information Related to Frequently Used Substances. Ann ICRP. 2015 Jul;44(2_suppl):7–321.

3.     Blake GM, Park-Holohan SJ, Cook GJR, Fogelman I. Quantitative studies of bone with the use of 18F-fluoride and 99mTc-methylene diphosphonate. Seminars in Nuclear Medicine. 2001 Jan;31(1):28–49.

4.     Usmani S, Marafi F, Esmail A, Ahmed N. A proof-of-concept study analyzing the clinical utility of fluorine-18-sodium fluoride PET-CT in skeletal staging of oncology patients with end-stage renal disease on dialysis. Nuclear Medicine Communications. 2017 Dec;38(12):1067–75.

5.     Beheshti M, Mottaghy FM, Payche F, Behrendt FFF, Van Den Wyngaert T, Fogelman I, et al. 18F-NaF PET/CT: EANM procedure guidelines for bone imaging. Eur J Nucl Med Mol Imaging. 2015 Oct;42(11):1767–77.

6.     Segall G, Delbeke D, Stabin MG, Even-Sapir E, Fair J, Sajdak R, et al. SNM Practice Guideline for Sodium18 F-Fluoride PET/CT Bone Scans 1.0. J Nucl Med. 2010 Nov;51(11):1813–20.